|
KIAA0226 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.772550E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.161400E-01 |
| Normal-vs-Stage2 |
1.759960E-01 |
| Normal-vs-Stage3 |
3.233400E-01 |
| Normal-vs-Stage4 |
2.640800E-01 |
| Stage1-vs-Stage2 |
3.063400E-01 |
| Stage1-vs-Stage3 |
1.511400E-01 |
| Stage1-vs-Stage4 |
1.448810E-01 |
| Stage2-vs-Stage3 |
5.482100E-02 |
| Stage2-vs-Stage4 |
6.351600E-02 |
| Stage3-vs-Stage4 |
6.146800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.644200E-01 |
| Normal-vs-AfricanAmerican |
7.066400E-01 |
| Normal-vs-Asian |
5.029200E-01 |
| Caucasian-vs-AfricanAmerican |
5.597800E-01 |
| Caucasian-vs-Asian |
4.331600E-01 |
| AfricanAmerican-vs-Asian |
5.103400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.190200E-01 |
| Normal-vs-Female |
4.402200E-02 |
| Male-vs-Female |
1.017220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.687000E-01 |
| Normal-vs-Extreme_Weight |
8.658800E-01 |
| Normal-vs-Obese |
2.252800E-01 |
| Normal-vs-Extreme_Obese |
4.484800E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.263800E-01 |
| Normal_Weight-vs-Obese |
3.478600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.951400E-01 |
| Extreme_Weight-vs-Obese |
2.674200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.239400E-01 |
| Obese-vs-Extreme_Obese |
8.401400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.872800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.233900E-02 |
| Normal-vs-Age(61-80Yrs) |
8.149600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.312630E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.242800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.764400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.164980E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.823700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.629600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.213000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.045900E-02 |
| Normal-VS-Type2 PRCC |
5.498100E-02 |
| Normal-VS-KIRP CIMP |
6.266400E-01 |
| Normal-VS-Unclassified PRCC |
1.016980E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.50656999999832E-05 |
| Type1 PRCC-VS-KIRP CIMP |
5.423600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.917000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.907420E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.077800E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.201600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.102200E-01 |
| Normal-vs-N1 |
2.830000E-01 |
| Normal-vs-N2 |
7.592600E-01 |
| N0-vs-N1 |
9.877800E-01 |
| N0-vs-N2 |
5.894200E-01 |
| N1-vs-N2 |
3.543000E-01 |
|
|
